Why is it so hard to create an artificial general intelligence?

Learn why creating artificial general intelligence is challenging and how TechnoLynx offers solutions to overcome these hurdles.

Why is it so hard to create an artificial general intelligence?

Written by TechnoLynx Published on 21 Feb 2024

Starting off to develop Artificial General Intelligence (AGI) requires a lot of excitement, but on the other hand, it is very hard to do it.

Why is it so hard to create AGI? Well, it’s like trying to capture the essence of human intelligence — the ability to learn, adapt, and comprehend — in lines of code. What is required is a detailed awareness of not just how the brain works but also the ability to replicate its cognitive processes in a digital format.

One of the things that we love at TechnoLynx is the chance to take up such difficult tasks as these. The team of pioneering experts in AI research and development we possess is dedicated to surpassing existing limits. Thanks to leading algorithms, state-of-the-art neural networks, and disruptive techniques, we are pioneering the way toward AGI breakthroughs.

Utilising the deep expertise and knowledge from TechnoLynx, you can exploit the power of AGI to transform industries, spark a technology boom, and create a new world. No matter if you are exploring AGI for research purposes, empowering business operations, or just looking for possibilities, TechnoLynx is your trusted partner every step of the way.

Contact us today to get your AGI journey started!

Image credit: scientificamerican.com

What Types of Generative AI Models Exist Beyond LLMs

What Types of Generative AI Models Exist Beyond LLMs

22/04/2026

LLMs dominate GenAI, but diffusion models, GANs, VAEs, and neural codecs handle image, audio, video, and 3D generation with different architectures.

Why Generative AI Projects Fail Before They Launch

Why Generative AI Projects Fail Before They Launch

21/04/2026

GenAI project failures cluster around scope inflation, evaluation gaps, and integration underestimation. The patterns are predictable and preventable.

How to Evaluate GenAI Use Case Feasibility Before You Build

How to Evaluate GenAI Use Case Feasibility Before You Build

20/04/2026

Most GenAI use cases fail at feasibility, not implementation. Assess data, accuracy tolerance, and integration complexity before building.

Visual Computing in Life Sciences: Real-Time Insights

Visual Computing in Life Sciences: Real-Time Insights

6/11/2025

Learn how visual computing transforms life sciences with real-time analysis, improving research, diagnostics, and decision-making for faster, accurate outcomes.

AI-Driven Aseptic Operations: Eliminating Contamination

AI-Driven Aseptic Operations: Eliminating Contamination

21/10/2025

Learn how AI-driven aseptic operations help pharmaceutical manufacturers reduce contamination, improve risk assessment, and meet FDA standards for safe, sterile products.

AI Visual Quality Control: Assuring Safe Pharma Packaging

AI Visual Quality Control: Assuring Safe Pharma Packaging

20/10/2025

See how AI-powered visual quality control ensures safe, compliant, and high-quality pharmaceutical packaging across a wide range of products.

AI for Reliable and Efficient Pharmaceutical Manufacturing

AI for Reliable and Efficient Pharmaceutical Manufacturing

15/10/2025

See how AI and generative AI help pharmaceutical companies optimise manufacturing processes, improve product quality, and ensure safety and efficacy.

Barcodes in Pharma: From DSCSA to FMD in Practice

Barcodes in Pharma: From DSCSA to FMD in Practice

25/09/2025

What the 2‑D barcode and seal on your medicine mean, how pharmacists scan packs, and why these checks stop fake medicines reaching you.

Pharma’s EU AI Act Playbook: GxP‑Ready Steps

Pharma’s EU AI Act Playbook: GxP‑Ready Steps

24/09/2025

A clear, GxP‑ready guide to the EU AI Act for pharma and medical devices: risk tiers, GPAI, codes of practice, governance, and audit‑ready execution.

Cell Painting: Fixing Batch Effects for Reliable HCS

Cell Painting: Fixing Batch Effects for Reliable HCS

23/09/2025

Reduce batch effects in Cell Painting. Standardise assays, adopt OME‑Zarr, and apply robust harmonisation to make high‑content screening reproducible.

Explainable Digital Pathology: QC that Scales

Explainable Digital Pathology: QC that Scales

22/09/2025

Raise slide quality and trust in AI for digital pathology with robust WSI validation, automated QC, and explainable outputs that fit clinical workflows.

Validation‑Ready AI for GxP Operations in Pharma

Validation‑Ready AI for GxP Operations in Pharma

19/09/2025

Make AI systems validation‑ready across GxP. GMP, GCP and GLP. Build secure, audit‑ready workflows for data integrity, manufacturing and clinical trials.

Edge Imaging for Reliable Cell and Gene Therapy

17/09/2025

Edge imaging transforms cell & gene therapy manufacturing with real‑time monitoring, risk‑based control and Annex 1 compliance for safer, faster production.

AI in Genetic Variant Interpretation: From Data to Meaning

15/09/2025

AI enhances genetic variant interpretation by analysing DNA sequences, de novo variants, and complex patterns in the human genome for clinical precision.

AI Visual Inspection for Sterile Injectables

11/09/2025

Improve quality and safety in sterile injectable manufacturing with AI‑driven visual inspection, real‑time control and cost‑effective compliance.

Predicting Clinical Trial Risks with AI in Real Time

5/09/2025

AI helps pharma teams predict clinical trial risks, side effects, and deviations in real time, improving decisions and protecting human subjects.

Generative AI in Pharma: Compliance and Innovation

1/09/2025

Generative AI transforms pharma by streamlining compliance, drug discovery, and documentation with AI models, GANs, and synthetic training data for safer innovation.

AI for Pharma Compliance: Smarter Quality, Safer Trials

27/08/2025

AI helps pharma teams improve compliance, reduce risk, and manage quality in clinical trials and manufacturing with real-time insights.

Markov Chains in Generative AI Explained

31/03/2025

Discover how Markov chains power Generative AI models, from text generation to computer vision and AR/VR/XR. Explore real-world applications!

Augmented Reality Entertainment: Real-Time Digital Fun

28/03/2025

See how augmented reality entertainment is changing film, gaming, and live events with digital elements, AR apps, and real-time interactive experiences.

Optimising LLMOps: Improvement Beyond Limits!

2/01/2025

LLMOps optimisation: profiling throughput and latency bottlenecks in LLM serving systems and the infrastructure decisions that determine sustainable performance under load.

Why do we need GPU in AI?

16/07/2024

Discover why GPUs are essential in AI. Learn about their role in machine learning, neural networks, and deep learning projects.

Exploring Diffusion Networks

10/06/2024

Diffusion networks explained: the forward noising process, the learned reverse pass, and how these models are trained and used for image generation.

Retrieval Augmented Generation (RAG): Examples and Guidance

23/04/2024

Learn about Retrieval Augmented Generation (RAG), a powerful approach in natural language processing that combines information retrieval and generative AI.

Case-Study: Text-to-Speech Inference Optimisation on Edge (Under NDA)

12/03/2024

See how our team applied a case study approach to build a real-time Kazakh text-to-speech solution using ONNX, deep learning, and different optimisation methods.

Generating New Faces

6/10/2023

With the hype of generative AI, all of us had the urge to build a generative AI application or even needed to integrate it into a web application.

AI in drug discovery

22/06/2023

A new groundbreaking model developed by researchers at the MIT utilizes machine learning and AI to accelerate the drug discovery process.

Case-Study: Generative AI for Stock Market Prediction

6/06/2023

Case study on using Generative AI for stock market prediction. Combines sentiment analysis, natural language processing, and large language models to identify trading opportunities in real time.

Case-Study: Performance Modelling of AI Inference on GPUs

15/05/2023

Learn how TechnoLynx helps reduce inference costs for trained neural networks and real-time applications including natural language processing, video games, and large language models.

3 Ways How AI-as-a-Service Burns You Bad

4/05/2023

Listen what our CEO has to say about the limitations of AI-as-a-Service.

Generative models in drug discovery

26/04/2023

Traditionally, drug discovery is a slow and expensive process that involves trial and error experimentation.

Consulting: AI for Personal Training Case Study - Kineon

2/11/2022

TechnoLynx partnered with Kineon to design an AI-powered personal training concept, combining biosensors, machine learning, and personalised workouts to support fitness goals and personal training certification paths.